Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

N Engl J Med. 2020 Feb 6;382(6):586. doi: 10.1056/NEJMx190039. Epub 2019 Dec 27.
No abstract available

Publication types

  • Published Erratum